Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates.
about
Synthesis and Anti-HCV Activity of a Novel 2',3'-Dideoxy-2'-α-fluoro-2'-β-C-methyl Guanosine Phosphoramidate Prodrug.Kinetin Riboside and Its ProTides Activate the Parkinson's Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial DepolarizationImmucillins in Infectious Diseases.Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: Mechanism of action and efficacy in nonclinical models.
P2860
Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates.
@en
type
label
Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates.
@en
prefLabel
Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates.
@en
P2093
P1476
Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates.
@en
P2093
Ageo Miccoli
Hachemi Kadri
Peter J Thornton
P304
10400-10410
P356
10.1021/ACS.JMEDCHEM.6B00523
P407
P577
2016-08-25T00:00:00Z